Based on the analysis of the most recent data and trends (gathered in The Global Pharma Market position paper), we estimate that over the 2025 – 2030 period the global pharma market should:
– Grow 2.1 times faster than other sectors
– Remain almost 2 times more profitable
If the global market size should exhibit a 6.5% growth p.a., its average profitability is likely to decrease from 32% to 30%
The Most-Favored Nation (MFN) pricing policy introduced by the US Government is aggravating the market instability and potentially reshaping national markets’ attractiveness
Due to increasing price pressures and taxes, we anticipate the French pharma market to step back from the 5th to the 7th position in value between 2025 and 2030, while its average contribution to global profits should be reduced from ~1.5% to ~1.3%
